In mouse models, intratumoral injection of the Cas9/sgPLK-1 plasmid into melanoma-bearing mice significantly downregulated polo-like kinase 1 (PLK-1) protein expression, resulting in over 67% inhibition of tumor growth [79]. The gene discussed is PLK1; the disease is melanoma.